Economic costs of chikungunya virus in Colombia

Objective: The aim of the present study was to estimate the economic impact of chikungunya virus (CHIKV) infection in Colombia from a societal perspective. Methods: We conducted a retrospective, bottom-up cost-of-illness study in clinically confirmed cases during the first chikungunya (CHIK) outbrea...

Full description

Autores:
Alvis Zakzuk, Nelson Jose
Díaz Jiménez, Diana
Castillo Rodríguez, Liliana
Castañeda Orjuela, Carlos Andres
Paternina Caicedo, Angel Jose
Pinzón Redondo, Hernando Samuel
Carrasquilla Sotomayor, María
Alvis Guzman, Nelson Rafae
De La Hoz Restrepo, Fernando
Tipo de recurso:
Article of journal
Fecha de publicación:
2018
Institución:
Corporación Universidad de la Costa
Repositorio:
REDICUC - Repositorio CUC
Idioma:
eng
OAI Identifier:
oai:repositorio.cuc.edu.co:11323/4618
Acceso en línea:
http://hdl.handle.net/11323/4618
https://repositorio.cuc.edu.co/
Palabra clave:
Chikungunya virus
Colombia
Cost
Disease outbreak
Economic cost
Virus chikungunya
Costo
Brote de enfermedad
Costo económico
Rights
openAccess
License
Attribution-NonCommercial-ShareAlike 4.0 International
Description
Summary:Objective: The aim of the present study was to estimate the economic impact of chikungunya virus (CHIKV) infection in Colombia from a societal perspective. Methods: We conducted a retrospective, bottom-up cost-of-illness study in clinically confirmed cases during the first chikungunya (CHIK) outbreak in Colombia in 2014. Direct and indirect costs were estimated per patient. Economic costs were calculated by the addition of direct costs (direct medical costs and out-of-pocket heath expenditures) and indirect cost as a result of loss of productivity. Results: A total of 126 patients (67 children and 59 adults) with CHIK were included. The median of the direct medical cost in children was US$257.9 (interquartile range [IQR] 121.7–563.8), and US$66.6 (IQR 26.5–317.3) for adults. The productivity loss median expenditures reached US$81.3 (IQR 72.2–203.2) per adult patient. The median economic cost in adults as a result of CHIK was US$152.9 (IQR 101.0–539.6), of which 53.2% was a result of indirect costs. Out-of-pocket expenditures comprised 3.3% of all economic costs. Conclusions: Our study can help health decision makers to properly assess the burden of disease caused by CHIK in Colombia, an endemic tropical country. We recommend to strength the health information systems and to continue investing in public health measures to prevent CHIK.